Improvements to accommodating intraocular optic assemblies are disclosed herein. The accommodating intraocular optic assembly can include an optic and at least one stanchion. The at least one stanchion can extend a length between a base end and a distal end. The distal end can be operably engaged with the optic directly or indirectly. The at least one stanchion can include an outer sleeve defining a through-aperture. The at least one stanchion can also include at least one inner member positioned within the through-aperture.

Penile implant and system comprising such an implant. The penile implant comprises a number of features which improves the function of the penile implant, e.g. a certain surface structure and portions with specific functions.

A filtering device for removing particles from a fluid of a patient is provided. The filtering device being implantable in the patient's body and comprising a cassette comprising a revolving member, said revolving member having at least two segments each holding a respective filter. The device further comprises a tube forming a fluid passageway through one of the filters in said cassette, wherein the cassette is adapted to, upon revolution of the revolving cylinder, change the filter positioned in the fluid passageway from a first one of said filters to a second one of said filters, thereby allowing particles present on the first filter to be moved away from the fluid passageway, while at the same time changing the filter positioned in the fluid passageway.

Ophthalmic devices having elastic electrodes are disclosed herein. An example ophthalmic device may be an intraocular lens that includes a support structure, two optical windows, two immiscible fluids, and an elastic electrode. The support structure may have an inner surface defining an aperture with first and second optical windows disposed on opposite sides of the support structure and spanning the aperture. The two immiscible liquids may be disposed in a cavity formed by the aperture and the first and second optical windows, and the elastic electrode may be disposed on the inner surface. The elastic electrode may be formed from an elastic metal alloy having a minimum yield strain of 0.25%.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (“V-VIS”) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

An intraocular implant device for comprehensive intraocular vision advancement includes an intraocular implant body shaped for positioning inside a lens chamber of an eye. In some embodiments, the implant includes an optical adjustable base accommodating lens configured to provide both base adjustment and accommodation. In further embodiments, the implant includes a photoelectric sensor operable to receive incident light through the cornea and to convert the received light into electrical energy for use with one or more circuit components disposed on the body, and wherein the photoelectric sensor is also operable to convert the received light into image data. The ocular implant device may include a projector for projecting the image data onto the retina of a user. The ocular implant may additionally include an autofocusing digital camera, an autofocusing electromechanical lens array, and sensors for detecting glucose levels and/or intraocular eye pressure.

An anatomy-specific implant for neuroplastic surgery. The implant includes a soft tissue implant component designed within and adapted to replace or restore missing soft tissue in a skull, joint or spine of the patient, wherein the soft tissue implant component is adapted to be coupled by an interdigitated connection to a rigid component. The rigid component can be a skull implant adapted to replace missing cranial or vertebral bone, or healthy cranial or vertebral bone, either of which can have downward extending catheters for medicinal brain or spinal cord infusion to help bypass the blood-brain barrier via multiphase flow. The soft tissue implant may include a functional component having neurotechnologies such as MRI-lucent pumps, Bluetooth connection systems, refillable diaphragms, remote imaging devices, wireless charging capabilities, and/or informative biosensors. The soft tissue implant component may be interchangeable with another soft tissue implant component in plug-and-play fashion.

Systems, devices, kits, and methods are described for securing a bioprosthetic heart valve within an anatomical feature of a patient. Kits can comprise a bioprosthetic heart valve, a curable composition, and an applicator configured to deliver the curable composition to a target area. The bioprosthetic heart valve can comprise a support structure and one or more valve leaflets coupled thereto. The support structure can comprise a sewing portion peripheral of the bioprosthetic heart valve. The support structure and the valve leaflets can define a central flow orifice. The curable composition can comprise a pre-polymer composition and an initiator. Methods can comprise positioning the bioprosthetic heart valve within the anatomical feature of a patient, applying the curable composition to one or both of the bioprosthetic heart valve and the anatomical feature, and curing the curable composition for a cure time. The applying can be performed before or after the positioning.

An artificial valve for implantation in a mammal body, in or adjacent to a mammal blood vessel, the artificial valve comprising a casing and a closing mechanism, with at least part of said closing mechanism being a first moving part adapted to make movements relative to said casing. The movements are movements to assume a fully open and a fully closed position for opening and closing, respectively, the blood flow through said blood vessel, as well as at least one position in between said fully open and fully closed positions. The first moving part is adapted to receive energy for at least one of its movements at least in part from an energy device which is also comprised in the artificial valve and arranged to be placed external to said blood vessel.

A blood clot removal method for removing blood clots from the vascular system of a patient, the blood clot removal method carried out on an implantable device in the patient's body and comprising: allowing a blood flow through a passageway between a first side wall and a second side wall, filtering blood clots with a filter provided in the blood flow passageway, and cleaning the filter with a cleaning device, wherein the cleaning device is moved from the first side wall towards the second side wall to move blood clots away from the blood flow passageway.